Journal profile · ONCOLOGY

Onkourologiya

ISSN 1726-9776 · eISSN 1996-1812 · ABV-press · Russian Federation

Onkourologiya: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; no APC; review about 10 weeks (community reports); 56 articles in 2025; indexed in ESCI and Scopus.

Impact factor—No published value
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review timeabout 10 weeksCommunity average
APCNo APCFully open access
Acceptance—No reports yet
Articles per year562025 · OpenAlex count

Scope

Aims, scope and focus

Onkourologiya is published by ABV-press and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Prostate Cancer Treatment and Research, Renal cell carcinoma treatment and Bladder and Urothelial Cancer Treatments, together about 40.2% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)

The main objective of the journal "Cancer urology" is publishing up-to-date information about scientific clinical researches, diagnostics, treatment of oncologic urological diseases. The aim of the edition is to inform the experts on oncologic urology about achievements in this area, to build understanding of the necessary integrated interdisciplinary approach in therapy, alongside with urologists, combining efforts of doctors of various specialties (cardiologists, pediatricians, chemotherapeutists et al.), to contribute to raising the effectiveness of oncologic patients’ treatment.

From the journal's Aims & Scope

Research area (LetPub): ONCOLOGY

Editor-in-chief Alekseev, Boris Ya.Publisher website

Editorial board by country: none in mainland China; most named Russia 33, United States 2, Germany 2, Italy 1, Israel 1 (40 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Prostate Cancer Treatment and ResearchMedicine14.8%
  2. Renal cell carcinoma treatmentMedicine13.7%
  3. Bladder and Urothelial Cancer TreatmentsMedicine11.6%
  4. Prostate Cancer Diagnosis and TreatmentMedicine10.7%
  5. Renal and related cancersBiochemistry, Genetics and Molecular Biology6.2%
  6. Urinary and Genital Oncology StudiesMedicine6%
  7. Multiple and Secondary Primary CancersMedicine4.6%
  8. Urological Disorders and TreatmentsMedicine4.2%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorOncologyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorOncologyZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ESCIScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

Web of ScienceDOAJPublisher website

Other: Google Scholar, EBSCO, OCLC

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

CiteScore 2026-06
0.4LetPub ·
SJR 2026-06
0.13LetPub ·
SNIP 2026-06
0.14LetPub ·
h-index
10OpenAlex ·
i10-index
10OpenAlex ·
2-year mean citedness
0.28OpenAlex ·
Share of gold OA articles
92.31%LetPub ·

Volume

Articles per year
66LetPub ·

Articles by year OpenAlex count · 834 in total · the current year is incomplete

YearArticlesOpen accessCitations
202647472
2025565614
2024636331
2023696949
2022727257
20218686119

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
about 10 weeksLetPub ·
Peer review
Double blind peer reviewLetPub

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessOpenAlex

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
LetPubNo APCNo—

Other charges and waivers (author guidelines)

Other fees
No other fees
Submission fee
No submission fee

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare2 items from the author guidelines
Keywords
≥ 3
Reference style
Vancouver
Publisher website · model-extracted, each line checked against the text
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, License & copyright, Peer review, Plagiarism, Preprints
Authorship 6.2.1 Authorship and authors’ contributions

According to the recommendations of the ICMJE, the right to be referred as the author have those persons who made significant contribution to the conception and design of the study or in the data analysis and its interpretation, actively participated in drafting the article or making fundamental changes, participated in the final approval of the version that is to be published and ready to take re…

Source ↗Publisher website ·
Conflicts of interest 6.2.2 Conflict of interest

At the end of the article you must specify conflicts of interest for all authors. Conflict of interest implies the existence of any relations and/or personal interest that potentially can affect results, interpretation of data, its objective perception, such as financial relations and cooperation with any organizations (e.g., receipt of fees, educational grants, participation in expert councils, m…

Source ↗Publisher website ·
License & copyright Copyright Notice

Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, addition…

Source ↗Publisher website ·
Peer review Peer Review Process

Review of the articles for publication takes at least 8 weeks. Model summary

A double-blind peer review method is mandatory for processing of all scientific manuscripts submitted to the editorial stuff of "Onkourologiya" (“Cancer Urology”). This implies that neither the reviewer is aware of the authorship of the manuscript, nor the author maintains any contact with the reviewer. Members of the editorial board and leading Russian and international experts in corresponding a…

Source ↗Publisher website ·
Plagiarism Borrowing and Plagiarism

Publication of works containing plagiarism of text, ideas, data is prohibited. Authors should submit fully original works. Results of other authors’ work should be appropriately cited or quoted; quotations of a text previously published should be written as the direct speech with the obligatory indication of the original source. The editorial board of the journal checks the material using plagiari…

Source ↗Publisher website ·
Preprints Preprint and postprint Policy

Prior to acceptance and publication in "Cancer Urology", authors may make their submissions available as preprints on personal or public websites. As part of submission process, authors are required to confirm that the submission has not been previously published, nor has been submitted. After a manuscript has been published in "Cancer Urology" we suggest that the link to the article on journal's …

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
ABV-press
Country or region
Russian Federation
Language
Russian
ISSN
1726-9776
Electronic ISSN
1996-1812
Latest issue on the website
Volume 22, Issue 1 (2026)
Official links

FAQ

Frequently asked questions about Onkourologiya

What CAS zone is Onkourologiya in?

In the 2025 upgraded edition of the CAS Journal Ranking, Onkourologiya is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

How long does peer review take at Onkourologiya?

Authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of Onkourologiya?

According to the journal's author guidelines: Keywords: ≥ 3; Reference style: Vancouver. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Where are the editorial board members of Onkourologiya based?

Of the 40 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Russia (33), United States (2) and Germany (2). Counted from the institutions listed on the board page; for reference only.

Which databases index Onkourologiya?

According to LetPub and DOAJ records, Onkourologiya is indexed in ESCI and Scopus. The journal's website also lists Web of Science and DOAJ; that list has not been checked against each database.

Is Onkourologiya open access, and what is the APC?

Onkourologiya is a fully open-access journal. It charges no article processing charge.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .